Evidence map›Paper›PMID 41952145›Full record

ArticleMicrobial cell factories2026

Heterologous expression of 1,4-benzoquinone reductases from white-rot fungi in Saccharomyces cerevisiae confers protection against p-benzoquinone toxicity.

Mateo Bello-Villarino, Leif J Jönsson

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mateo Bello-VillarinoDepartment of Chemistry, Umeå University, SE-901 87, Umeå, Sweden.
Leif J JönssonDepartment of Chemistry, Umeå University, SE-901 87, Umeå, Sweden. leif.jonsson@umu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthanolic fermentation by Saccharomyces cerevisiae is a key part of biochemical conversion of lignocellulosic feedstocks. Although abundant, lignocellulose typically requires pretreatment for efficient bioconversion. During pretreatment, inhibitory compounds are formed. p-Benzoquinone (p-BQ) is a lignin-derived inhibitor that is highly toxic to S. cerevisiae. White-rot fungi, efficient degraders of lignin, produce 1,4-benzoquinone reductases (QRDs), which have been suggested to play a role in defense against oxidative stress caused by quinones formed during lignin biodegradation. The hypothesis that QRDs from white-rot fungi can be used to engineer S. cerevisiae with improved resistance against quinone toxicity was explored in experiments with QRD-encoding genes, with and without an N-terminal putative leader sequence, the function of which has not yet been deciphered.

resultsConstitutive recombinant expression of QRDs from the white-rot fungi Trametes versicolor and Phanerochaete chrysosporium in S. cerevisiae resulted in increased tolerance against p-BQ toxicity compared to an empty vector control containing insert-less plasmid, with QRD-expressing constructs requiring 34 to 42% less time to reach half-time of maximum growth in p-BQ conditions adverse for the growth of the empty vector control (10 mg L

conclusionsHeterologous expression of QRDs from white-rot fungi in S. cerevisiae confers protection against p-BQ toxicity. This investigation supports a role of QRD in the protection against toxic quinones and proposes a biodetoxification strategy against lignin-derived inhibitory p-BQ which can occur simultaneously with fermentation of sugars into ethanol in S. cerevisiae.

Indexed as

BenzoquinonesPhanerochaeteQuinone ReductasesSaccharomyces cerevisiaeTrametesLigninPolyporaceaeBenzoquinonesLigninquinoneQuinone Reductases1,4-Benzoquinone reductaseBioethanolInhibitorLigninp-BenzoquinonePhanerochaete chrysosporiumSaccharomyces cerevisiaeTrametes versicolor

Identifiers

PMID41952145
PMCPMC13088443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.